Gut microbiota-derived short-chain fatty acids mediate the antifibrotic effects of traditional Chinese medicine in diabetic nephropathy
Diabetic nephropathy (DN), a devastating microvascular complication affecting 40% of diabetic patients worldwide, represents the leading cause of end-stage renal disease (ESRD) and poses a substantial therapeutic challenge due to its complex pathogenesis involving progressive renal fibrosis. Note: T...
| Published in: | Frontiers in Endocrinology |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-09-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1643515/full |
